237 related articles for article (PubMed ID: 17993646)
1. Regulation of interleukin-6-induced hepatic insulin resistance by mammalian target of rapamycin through the STAT3-SOCS3 pathway.
Kim JH; Kim JE; Liu HY; Cao W; Chen J
J Biol Chem; 2008 Jan; 283(2):708-15. PubMed ID: 17993646
[TBL] [Abstract][Full Text] [Related]
2. Activation of the mammalian target of rapamycin pathway acutely inhibits insulin signaling to Akt and glucose transport in 3T3-L1 and human adipocytes.
Tremblay F; Gagnon A; Veilleux A; Sorisky A; Marette A
Endocrinology; 2005 Mar; 146(3):1328-37. PubMed ID: 15576463
[TBL] [Abstract][Full Text] [Related]
3. Increased activation of the mammalian target of rapamycin pathway in liver and skeletal muscle of obese rats: possible involvement in obesity-linked insulin resistance.
Khamzina L; Veilleux A; Bergeron S; Marette A
Endocrinology; 2005 Mar; 146(3):1473-81. PubMed ID: 15604215
[TBL] [Abstract][Full Text] [Related]
4. Improved insulin sensitivity by rapamycin is associated with reduction of mTOR and S6K1 activities in L6 myotubes.
Hwang SL; Li X; Lee JY; Chang HW
Biochem Biophys Res Commun; 2012 Feb; 418(2):402-7. PubMed ID: 22281494
[TBL] [Abstract][Full Text] [Related]
5. Paradoxical effect of rapamycin on inflammatory stress-induced insulin resistance in vitro and in vivo.
Yang P; Zhao Y; Zhao L; Yuan J; Chen Y; Varghese Z; Moorhead JF; Chen Y; Ruan XZ
Sci Rep; 2015 Oct; 5():14959. PubMed ID: 26449763
[TBL] [Abstract][Full Text] [Related]
6. [Effect of AMPK/mTOR/S6K1 pathways and the insulin-sensitizing effect for adiponectin in endometrial cancer cells].
Cai ZF; Deng L; Wang MM; Zhang JQ; Li L
Zhonghua Fu Chan Ke Za Zhi; 2018 Aug; 53(8):554-560. PubMed ID: 30138966
[No Abstract] [Full Text] [Related]
7. Chronic inhibition of the mTORC1/S6K1 pathway increases insulin-induced PI3K activity but inhibits Akt2 and glucose transport stimulation in 3T3-L1 adipocytes.
Veilleux A; Houde VP; Bellmann K; Marette A
Mol Endocrinol; 2010 Apr; 24(4):766-78. PubMed ID: 20203102
[TBL] [Abstract][Full Text] [Related]
8. mTOR inhibition by rapamycin prevents beta-cell adaptation to hyperglycemia and exacerbates the metabolic state in type 2 diabetes.
Fraenkel M; Ketzinel-Gilad M; Ariav Y; Pappo O; Karaca M; Castel J; Berthault MF; Magnan C; Cerasi E; Kaiser N; Leibowitz G
Diabetes; 2008 Apr; 57(4):945-57. PubMed ID: 18174523
[TBL] [Abstract][Full Text] [Related]
9. Regulation of ribosomal S6 kinase 2 by mammalian target of rapamycin.
Park IH; Bachmann R; Shirazi H; Chen J
J Biol Chem; 2002 Aug; 277(35):31423-9. PubMed ID: 12087098
[TBL] [Abstract][Full Text] [Related]
10. Serine phosphorylation and maximal activation of STAT3 during CNTF signaling is mediated by the rapamycin target mTOR.
Yokogami K; Wakisaka S; Avruch J; Reeves SA
Curr Biol; 2000 Jan; 10(1):47-50. PubMed ID: 10660304
[TBL] [Abstract][Full Text] [Related]
11. Cardamonin ameliorates insulin resistance induced by high insulin and high glucose through the mTOR and signal pathway.
Niu P; Zhang Y; Shi D; Chen Y; Deng J
Planta Med; 2013 Apr; 79(6):452-8. PubMed ID: 23512499
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a conserved C-terminal motif (RSPRR) in ribosomal protein S6 kinase 1 required for its mammalian target of rapamycin-dependent regulation.
Schalm SS; Tee AR; Blenis J
J Biol Chem; 2005 Mar; 280(12):11101-6. PubMed ID: 15659381
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological inhibition of S6K1 increases glucose metabolism and Akt signalling in vitro and in diet-induced obese mice.
Shum M; Bellmann K; St-Pierre P; Marette A
Diabetologia; 2016 Mar; 59(3):592-603. PubMed ID: 26733005
[TBL] [Abstract][Full Text] [Related]
14. Rapamycin promotes vascular smooth muscle cell differentiation through insulin receptor substrate-1/phosphatidylinositol 3-kinase/Akt2 feedback signaling.
Martin KA; Merenick BL; Ding M; Fetalvero KM; Rzucidlo EM; Kozul CD; Brown DJ; Chiu HY; Shyu M; Drapeau BL; Wagner RJ; Powell RJ
J Biol Chem; 2007 Dec; 282(49):36112-20. PubMed ID: 17908691
[TBL] [Abstract][Full Text] [Related]
15. Rescuing 3T3-L1 adipocytes from insulin resistance induced by stimulation of Akt-mammalian target of rapamycin/p70 S6 kinase (S6K1) pathway and serine phosphorylation of insulin receptor substrate-1: effect of reduced expression of p85alpha subunit of phosphatidylinositol 3-kinase and S6K1 kinase.
Adochio R; Leitner JW; Hedlund R; Draznin B
Endocrinology; 2009 Mar; 150(3):1165-73. PubMed ID: 18948408
[TBL] [Abstract][Full Text] [Related]
16. hVps34 is a nutrient-regulated lipid kinase required for activation of p70 S6 kinase.
Byfield MP; Murray JT; Backer JM
J Biol Chem; 2005 Sep; 280(38):33076-82. PubMed ID: 16049009
[TBL] [Abstract][Full Text] [Related]
17. Suppressor of Cytokine Signaling-3 (SOCS-3) Induces Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) Expression in Hepatic HepG2 Cell Line.
Ruscica M; Ricci C; Macchi C; Magni P; Cristofani R; Liu J; Corsini A; Ferri N
J Biol Chem; 2016 Feb; 291(7):3508-19. PubMed ID: 26668321
[TBL] [Abstract][Full Text] [Related]
18. Amino Acids Attenuate Insulin Action on Gluconeogenesis and Promote Fatty Acid Biosynthesis via mTORC1 Signaling Pathway in trout Hepatocytes.
Dai W; Panserat S; Plagnes-Juan E; Seiliez I; Skiba-Cassy S
Cell Physiol Biochem; 2015; 36(3):1084-100. PubMed ID: 26112996
[TBL] [Abstract][Full Text] [Related]
19. Mammalian target of rapamycin pathway regulates insulin signaling via subcellular redistribution of insulin receptor substrate 1 and integrates nutritional signals and metabolic signals of insulin.
Takano A; Usui I; Haruta T; Kawahara J; Uno T; Iwata M; Kobayashi M
Mol Cell Biol; 2001 Aug; 21(15):5050-62. PubMed ID: 11438661
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-6 inhibition of peroxisome proliferator-activated receptor alpha expression is mediated by JAK2- and PI3K-induced STAT1/3 in HepG2 hepatocyte cells.
Chew GS; Myers S; Shu-Chien AC; Muhammad TS
Mol Cell Biochem; 2014 Mar; 388(1-2):25-37. PubMed ID: 24242046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
